• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I期原发性子宫内膜癌不通过手术和放射治疗能治愈吗?

Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?

作者信息

Bokhman J V, Chepick O F, Volkova A T, Vishnevsky A S

出版信息

Gynecol Oncol. 1985 Feb;20(2):139-55. doi: 10.1016/0090-8258(85)90135-0.

DOI:10.1016/0090-8258(85)90135-0
PMID:3972284
Abstract

The data on 19 cases of primary endometrial carcinoma, stage I (mean age 28.0 years), cured by the administration of hydroxyprogesterone caproate without surgery and radiation therapy are presented. Clinical recovery in 15 cases was confirmed by repeated cytological and histological examinations of the endometrium. Hydroxyprogesterone caproate dose per course ranged within 25.0-83.0 g. In 4 patients with moderately differentiated cancer (G2), hormonal treatment was carried out in combination with chemotherapy. When tumor regression was confirmed histologically, steroid contraceptives were administered to induce an artificial menstrual cycle. At the closing stage of therapy clomiphene citrates were given in succession to restore the ovulatory cycle. Perspectives of administration of progestogens in young women with stage I endometrial carcinoma as a separate method of therapy are discussed.

摘要

本文报道了19例Ⅰ期原发性子宫内膜癌患者(平均年龄28.0岁),在未接受手术和放疗的情况下,通过使用己酸羟孕酮治愈的病例。通过对子宫内膜进行反复的细胞学和组织学检查,证实15例患者临床康复。每个疗程己酸羟孕酮的剂量范围为25.0 - 83.0 g。对于4例中分化癌(G2)患者,激素治疗与化疗联合进行。当组织学证实肿瘤消退时,给予甾体避孕药以诱导人工月经周期。在治疗末期,连续给予枸橼酸氯米芬以恢复排卵周期。本文还讨论了将孕激素作为Ⅰ期子宫内膜癌年轻女性的一种单独治疗方法的应用前景。

相似文献

1
Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?I期原发性子宫内膜癌不通过手术和放射治疗能治愈吗?
Gynecol Oncol. 1985 Feb;20(2):139-55. doi: 10.1016/0090-8258(85)90135-0.
2
[Is a cure possible for primary state-I endometrial cancer using drug therapy?].药物治疗能否治愈I期原发性子宫内膜癌?
Vopr Onkol. 1982;28(3):34-42.
3
Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.I期子宫内膜癌中辅助使用己酸羟孕酮:部分血液淋巴细胞亚群数量及反应性的变化
Gynecol Oncol. 1982 Dec;14(3):355-64. doi: 10.1016/0090-8258(82)90110-x.
4
[Adjuvant gestagen therapy of endometrial carcinoma (author's transl)].子宫内膜癌的辅助孕激素治疗(作者译)
Zentralbl Gynakol. 1981;103(21):1289-93.
5
[Chemotherapy and endocrine therapy of endometrial carcinoma].[子宫内膜癌的化疗与内分泌治疗]
Gan No Rinsho. 1990 Aug;36(10):1161-5.
6
Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.己酸羟孕酮用于原发性子宫内膜癌的辅助激素治疗。
Gynecol Oncol. 1981 Jun;11(3):371-8. doi: 10.1016/0090-8258(81)90051-2.
7
A randomized trial of adjuvant progestagen in early endometrial cancer.早期子宫内膜癌辅助孕激素治疗的随机试验。
Cancer. 1989 Sep 1;64(5):1011-6. doi: 10.1002/1097-0142(19890901)64:5<1011::aid-cncr2820640507>3.0.co;2-7.
8
Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer.己酸羟孕酮、他莫昔芬及其联合用药对子宫内膜癌患者肿瘤中甾体激素受体水平及生殖系统某些参数的影响。
Clin Exp Obstet Gynecol. 1990;17(3-4):159-62.
9
[Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].[孕激素治疗过程中子宫内膜腺棘皮癌的激素转化特征]
Vopr Onkol. 1981;27(10):52-6.
10
Effects of progestational agents in treatment of endometrial carcinoma.孕激素制剂在子宫内膜癌治疗中的作用
Obstet Gynecol. 1985 Jul;66(1):106-10.

引用本文的文献

1
Metformin and progestins in women with atypical hyperplasia or endometrial cancer: systematic review and meta-analysis.二甲双胍和孕激素在非典型增生或子宫内膜癌妇女中的应用:系统评价和荟萃分析。
Arch Gynecol Obstet. 2024 Jun;309(6):2289-2305. doi: 10.1007/s00404-024-07416-2. Epub 2024 Mar 19.
2
Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma.年轻的假定为IA期2级子宫内膜样腺癌患者的保留生育功能治疗
Front Oncol. 2020 Aug 25;10:1437. doi: 10.3389/fonc.2020.01437. eCollection 2020.
3
Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia.
高分化早期子宫内膜癌和复杂性不典型增生保留生育功能治疗方法的比较。
Oncotarget. 2017 May 3;8(34):57642-57653. doi: 10.18632/oncotarget.17588. eCollection 2017 Aug 22.
4
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment.在不适于根治性治疗的体弱老年子宫癌患者中放置释放孕激素的宫内节育器加姑息性放疗。
Oncol Lett. 2016 May;11(5):3446-3450. doi: 10.3892/ol.2016.4390. Epub 2016 Mar 29.
5
Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis.靶向葡萄糖调节蛋白78可消除Pten基因缺失驱动的AKT激活和子宫内膜样肿瘤发生。
Oncogene. 2015 Oct;34(43):5418-26. doi: 10.1038/onc.2015.4. Epub 2015 Feb 16.
6
Endometrial adenocarcinoma in a 27-year-old woman.一名27岁女性的子宫内膜腺癌。
Clin Med Insights Case Rep. 2010;3:31-9. doi: 10.4137/ccrep.s5346. Epub 2010 Aug 12.
7
Controversies in the management of endometrial carcinoma.子宫内膜癌管理中的争议
Obstet Gynecol Int. 2010;2010:862908. doi: 10.1155/2010/862908. Epub 2010 Jun 22.
8
Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report.早期子宫内膜癌保留生育功能治疗失败病例中孕激素受体缺失:一例报告
J Reprod Med. 2008 Nov;53(11):869-73.
9
Conservative management of patients with early endometrial carcinoma: a systematic review.早期子宫内膜癌患者的保守治疗:一项系统评价
Clin Transl Oncol. 2008 Mar;10(3):155-62. doi: 10.1007/s12094-008-0173-1.
10
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.早期子宫内膜癌:临床病理学、激素方面、分子遗传学、诊断与治疗
Int J Clin Oncol. 2006 Feb;11(1):13-21. doi: 10.1007/s10147-005-0546-1.